View Risk


Article data
Wei (2020)
Acute myocardial injury is common in patients with covid-19 and impairs their prognosis
http://dx.doi.org/10.1136/heartjnl-2020-317007.
https://pubmed.ncbi.nlm.nih.gov/32354798/

Results
Treatment
Concomitant medication (Treated with ACEi/ARB vs. Not received)
COVID-19 (severe/fatal)
Odds ratio: 2.820 (0.450-17.720) Univariate analysis

Study characteristics

China

Retrospective observational study

Medical records

101

Consecutive patients with laboratory-confirmed SARS-CoV-2 infection admitted to the Public Health Clinical Centre of Chengdu and West China Hospital, Sichuan University, between 16 January and 10 March 2020. Both institutions are certified covid-19 tertiary care hospitals and designated hub centres within Sichuan province.

Laboratory-confirmed cases were defined by a positive result on high-throughput sequencing or real-time reverse-transcriptase–PCR assay of nasal and/or pharyngeal swabs

0


Results

COVID-19 (severe/fatal)

0

need for ICU admission, mechanical ventilation and use of vasoactive agents, and death.

Treatment

Concomitant medication

none

Not received

Treated with ACEi/ARB

Odds ratio

2.820 (0.450-17.720)

No

No

No

none


Other information

none

Average

No

Go Back